Report - Lutz E. Pillunat - Glaukom · • Travoprost –intracamerales Implant (ENV515, Envisia Therapeutics) • Phase II b: 6,7 mmHg IOD –Senkung (28%) nach 25 Tagen vergleichbar mit

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form